REFERENCES
1. Yourkavitch J, Chetwynd EM. Toward consistency: updating lactation and breastfeeding terminology for population health research. J Hum Lact 2019;35:418-23.
2. WHO. The optimal duration of exclusive breastfeeding: report of an expert consultation. Available from: https://www.who.int/publications/i/item/WHO-NHD-01.09 [Last accessed on 21 Oct 2023].
3. Haroon S, Das JK, Salam RA, Imdad A, Bhutta ZA. Breastfeeding promotion interventions and breastfeeding practices: a systematic review. BMC Public Health 2013;13 Suppl 3:S20.
4. Tsang LPM, Ng DCC, Chan YH, Chen HY. Caring for the mother-child dyad as a family physician. Singapore Med J 2019;60:497-501.
6. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8.
7. Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. a clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-62.
8. Ballestri S, Zona S, Targher G, et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol 2016;31:936-44.
9. Udall JN Jr, Dixon M, Newman AP, Wright JA, James B, Bloch KJ. Liver disease in alpha 1-antitrypsin deficiency. a retrospective analysis of the influence of early breast- vs bottle-feeding. JAMA 1985;253:2679-82.
10. Bertrando S, Vajro P. NAFLD at the interface of the mother-infant dyad. Curr Pharm Des 2020;26:1119-25.
11. Gunderson EP, Jacobs DR Jr, Chiang V, et al. Duration of lactation and incidence of the metabolic syndrome in women of reproductive age according to gestational diabetes mellitus status: a 20-Year prospective study in CARDIA (Coronary Artery Risk Development in Young Adults). Diabetes 2010;59:495-504.
12. Natland ST, Nilsen TI, Midthjell K, Andersen LF, Forsmo S. Lactation and cardiovascular risk factors in mothers in a population-based study: the HUNT-study. Int Breastfeed J 2012;7:8.
13. Nguyen B, Jin K, Ding D. Breastfeeding and maternal cardiovascular risk factors and outcomes: A systematic review. PLoS One 2017;12:e0187923.
14. Rajaei S, Rigdon J, Crowe S, Tremmel J, Tsai S, Assimes TL. Breastfeeding duration and the risk of coronary artery disease. J Womens Health 2019;28:30-6.
15. Ajmera VH, Terrault NA, VanWagner LB, et al. Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women. J Hepatol 2019;70:126-32.
16. Park Y, Sinn DH, Oh JH, et al. The association between breastfeeding and nonalcoholic fatty liver disease in parous women: a nation-wide cohort study. Hepatology 2021;74:2988-97.
17. Mantovani A, Beatrice G, Zusi C, Dalbeni A. Breastfeeding duration and reduced risk of NAFLD in midlife of parous women. Explor Med 2021;2:378-81.
18. Karachaliou GS, Suzuki A, Patel VA, Bastian LA, Diehl AM, Abdelmalek MF; Duke NAFLD Clinical Research Working Group. Longer breastfeeding duration is associated with decreased risk of hepatic fibrosis among young women with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2023;10:S1542-3565(23)00449-4.
19. Butte NF, Hopkinson JM, Mehta N, Moon JK, Smith EO. Adjustments in energy expenditure and substrate utilization during late pregnancy and lactation. Am J Clin Nutr 1999;69:299-307.
20. Farahmand M, Rahmati M, Azizi F, Ramezani Tehrani F. Lactation duration and lifetime progression to metabolic syndrome in women according to their history of gestational diabetes: a prospective longitudinal community-based cohort study. J Transl Med 2023;21:177.
21. Aune D, Norat T, Romundstad P, Vatten LJ. Breastfeeding and the maternal risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Nutr Metab Cardiovasc Dis 2014;24:107-15.
22. Butte NF, King JC. Energy requirements during pregnancy and lactation. Public Health Nutr 2005;8:1010-27.
23. Houssay BA, Anderson E. Diabetogenic action of purified anterior pituitary hormones. Endocrinology 1949;45:627-9.
24. Macotela Y, Triebel J, Clapp C. Time for a new perspective on prolactin in metabolism. Trends Endocrinol Metab 2020;31:276-86.
25. Papazoglou AS, Leite AR. Prolactin levels and cardiovascular disease: a complicate relationship or a confounding association? Eur J Prev Cardiol 2023;18:zwad176.
26. Shao S, Yao Z, Lu J, et al. Ablation of prolactin receptor increases hepatic triglyceride accumulation. Biochem Biophys Res Commun 2018;498:693-9.
27. Zhang J, Guan J, Tang X, Xu J. Prolactin is a key factor for nonalcoholic fatty liver disease in obese children. Horm Metab Res 2023;55:251-5.
28. Zhang P, Ge Z, Wang H, et al. Prolactin improves hepatic steatosis via CD36 pathway. J Hepatol 2018;68:1247-55.
29. Xu P, Zhu Y, Ji X, Ma H, Zhang P, Bi Y. Lower serum PRL is associated with the development of non-alcoholic fatty liver disease: a retrospective cohort study. BMC Gastroenterol 2022;22:523.
30. Stuebe AM, Rich-Edwards JW. The reset hypothesis: lactation and maternal metabolism. Am J Perinatol 2009;26:81-8.
31. Donath SM, Amir LH. Does maternal obesity adversely affect breastfeeding initiation and duration? J Paediatr Child Health 2000;36:482-6.
32. Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol 2022;10:284-96.
33. Ramos-Roman MA, Syed-Abdul MM, Casey BM, Alger JR, Liu YL, Parks EJ. Lactation alters the relationship between liver lipid synthesis and hepatic fat stores in the postpartum period. J Lipid Res 2022;63:100288.
34. Nobili V, Bedogni G, Alisi A, et al. A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease. Arch Dis Child 2009;94:801-5.
35. Ayonrinde OT, Oddy WH, Adams LA, et al. Infant nutrition and maternal obesity influence the risk of non-alcoholic fatty liver disease in adolescents. J Hepatol 2017;67:568-76.
36. Abeysekera KW, Orr JG, Madley-Dowd P, et al. Association of maternal pre-pregnancy BMI and breastfeeding with NAFLD in young adults: a parental negative control study. Lancet Reg Health Eur 2021;10:100206.
37. Rajindrajith S, Pathmeswaran A, Jayasinghe C, et al. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community. BMC Gastroenterol 2017;17:135.
38. Cantoral A, Montoya A, Luna-Villa L, et al. Overweight and obesity status from the prenatal period to adolescence and its association with non-alcoholic fatty liver disease in young adults: cohort study. BJOG 2020;127:1200-9.
39. Gale C, Thomas EL, Jeffries S, et al. Adiposity and hepatic lipid in healthy full-term, breastfed, and formula-fed human infants: a prospective short-term longitudinal cohort study. Am J Clin Nutr 2014;99:1034-40.
40. Vogelezang S, Santos S, van der Beek EM, et al. Infant breastfeeding and childhood general, visceral, liver, and pericardial fat measures assessed by magnetic resonance imaging. Am J Clin Nutr 2018;108:722-9.
41. Mosca A, De Cosmi V, Parazzini F, et al. The role of genetic predisposition, programing during fetal life, family conditions, and post-natal diet in the development of pediatric fatty liver disease. J Pediatr 2019;211:72-7.e4.
42. Querter I, Pauwels NS, De Bruyne R, et al. Maternal and perinatal risk factors for pediatric nonalcoholic fatty liver disease: a systematic review. Clin Gastroenterol Hepatol 2022;20:740-55.
43. Fowden AL, Giussani DA, Forhead AJ. Intrauterine programming of physiological systems: causes and consequences. Physiology 2006;21:29-37.
44. Nobili V, Cianfarani S, Agostoni C. Programming, metabolic syndrome, and NAFLD: the challenge of transforming a vicious cycle into a virtuous cycle. J Hepatol 2010;52:788-90.
45. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115:e290-6.
46. Bruce KD, Cagampang FR, Argenton M, et al. Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology 2009;50:1796-808.
47. Forsén T, Eriksson JG, Tuomilehto J, Osmond C, Barker DJ. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ 1999;319:1403-7.
48. Oben JA, Mouralidarane A, Samuelsson AM, et al. Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice. J Hepatol 2010;52:913-20.
49. Toyama T, Nakamura H, Harano Y, et al. PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 2004;324:697-704.
50. Hill CJ, Lynch DB, Murphy K, et al. Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. Microbiome 2017;5:4.
51. O'Neill IJ, Sanchez Gallardo R, Saldova R, et al. Maternal and infant factors that shape neonatal gut colonization by bacteria. Expert Rev Gastroenterol Hepatol 2020;14:651-64.
52. Sousa P, Machado MV. MAFLD under the lens: the role of gut microbiota. Metab Target Organ Damage 2022;2:14.
53. Ho NT, Li F, Lee-Sarwar KA, et al. Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations. Nat Commun 2018;9:4169.
54. Horta BL, Victora CG, França GVA, et al. Breastfeeding moderates FTO related adiposity: a birth cohort study with 30 years of follow-up. Sci Rep 2018;8:2530.
55. Korpela K, de Vos WM. Infant gut microbiota restoration: state of the art. Gut Microbes 2022;14:2118811.
56. Wells JM, Gao Y, de Groot N, Vonk MM, Ulfman L, van Neerven RJJ. Babies, bugs, and barriers: dietary modulation of intestinal barrier function in early life. Annu Rev Nutr 2022;42:165-200.
57. Wu Y, Chen W, Guo M, et al. Metabolomics of extracellular vesicles: a future promise of multiple clinical applications. Int J Nanomedicine 2022;17:6113-29.
58. Jiang X, Wu Y, Zhong H, et al. Human milk-derived extracellular vesicles alleviate high fat diet-induced non-alcoholic fatty liver disease in mice. Mol Biol Rep 2023;50:2257-68.
59. Reif S, Atias A, Musseri M, Koroukhov N, Gerstl RG. Beneficial effects of milk-derived extracellular vesicles on liver fibrosis progression by inhibiting hepatic stellate cell activation. Nutrients 2022;14:4049.
60. Lonardo A, Singal AK, Osna N, Kharbanda KK. Effect of cofactors on NAFLD/NASH and MAFLD. a paradigm illustrating the pathomechanics of organ dysfunction. Metab Target Organ Damage 2022;2:12.
